United Therapeutics (UTHR) Assets (2009 - 2026)

United Therapeutics has disclosed Assets across 18 years of filings, most recently posting $7.2 billion for Q2 2026.

• In Q2 2026, Assets fell 8.7% year-over-year to $7.2 billion; the TTM figure through Jun 2026 stood at $7.2 billion (down 8.7% YoY), while the FY2025 annual figure was $7.9 billion, up 7.01% from the prior year.
• Assets came in at $7.2 billion for Q2 2026 at United Therapeutics, up from $6.7 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $7.9 billion in Q2 2025 to a low of $5.4 billion in Q1 2022.
• Average Assets over 5 years is $6.8 billion, with a median of $6.9 billion recorded in 2023.
• Year-over-year, Assets rose 21.48% in 2023 and decreased 13.3% in 2026.
• Over 5 years, Assets stood at $6.0 billion in 2022, then grew by 18.57% to $7.2 billion in 2023, then gained by 2.75% to $7.4 billion in 2024, then grew by 7.01% to $7.9 billion in 2025, then slipped by 8.37% to $7.2 billion in 2026.
• Per Business Quant data, the three most recent Assets figures were $7.2 billion in Q2 2026, $6.7 billion in Q1 2026, and $7.9 billion in Q4 2025.